{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:03:06Z","timestamp":1775574186541,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41409-025-02749-1","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:19:05Z","timestamp":1769617145000},"page":"437-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5301-556X","authenticated-orcid":false,"given":"Yizhou","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanling","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5067-5650","authenticated-orcid":false,"given":"Qingya","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-2598","authenticated-orcid":false,"given":"Sining","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-7744","authenticated-orcid":false,"given":"Haiping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-3863","authenticated-orcid":false,"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-7891","authenticated-orcid":false,"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2749_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/NAN.0b013e3181cfd392","volume":"33","author":"S Eisenberg","year":"2010","unstructured":"Eisenberg S. Refractory response to platelet transfusion therapy. J Infus Nurs. 2010;33:89\u201397.","journal-title":"J Infus Nurs"},{"key":"2749_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","volume":"142","author":"E Hod","year":"2008","unstructured":"Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142:348\u201360.","journal-title":"Br J Haematol"},{"key":"2749_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/bjh.13597","volume":"171","author":"SJ Stanworth","year":"2015","unstructured":"Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet refractoriness\u2013practical approaches and ongoing dilemmas in patient management. Br J Haematol. 2015;171:297\u2013305.","journal-title":"Br J Haematol"},{"key":"2749_CR4","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/j.1537-2995.2008.01799.x","volume":"48","author":"JL Kerkhoffs","year":"2008","unstructured":"Kerkhoffs JL, Eikenboom JC, van de Watering LM, van Wordragen-Vlaswinkel RJ, Wijermans PW, Brand A. The clinical impact of platelet refractoriness: correlation with bleeding and survival. Transfusion. 2008;48:1959\u201365.","journal-title":"Transfusion"},{"key":"2749_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bmt.1702490","volume":"26","author":"AA Toor","year":"2000","unstructured":"Toor AA, Choo SY, Little JA. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation. Bone Marrow Transpl. 2000;26:315\u201320.","journal-title":"Bone Marrow Transpl"},{"key":"2749_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.leukres.2017.08.015","volume":"61","author":"T Comont","year":"2017","unstructured":"Comont T, Tavitian S, Bardiaux L, Fort M, Debiol B, Mor\u00e8re D, et al. Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy. Leuk Res. 2017;61:62\u20137.","journal-title":"Leuk Res"},{"key":"2749_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/1096-8652(200008)64:4<251::AID-AJH3>3.0.CO;2-N","volume":"64","author":"KR Meehan","year":"2000","unstructured":"Meehan KR, Matias CO, Rathore SS, Sandler SG, Kallich J, LaBrecque J, et al. Platelet transfusions: utilization and associated costs in a tertiary care hospital. Am J Hematol. 2000;64:251\u20136.","journal-title":"Am J Hematol"},{"key":"2749_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood.V71.2.383.383","volume":"71","author":"JF Bishop","year":"1988","unstructured":"Bishop JF, McGrath K, Wolf MM, Matthews JP, De Luise T, Holdsworth R, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood. 1988;71:383\u20137.","journal-title":"Blood"},{"key":"2749_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0268-960X(90)90013-I","volume":"4","author":"MF Murphy","year":"1990","unstructured":"Murphy MF, Waters AH. Platelet transfusions: the problem of refractoriness. Blood Rev. 1990;4:16\u201324.","journal-title":"Blood Rev"},{"key":"2749_CR10","first-page":"200","volume":"66","author":"HA Doughty","year":"1994","unstructured":"Doughty HA, Murphy MF, Metcalfe P, Rohatiner AZ, Lister TA, Waters AH. Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sang. 1994;66:200\u20135.","journal-title":"Vox Sang"},{"key":"2749_CR11","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1182\/blood.V95.10.3168","volume":"95","author":"C Gouttefangeas","year":"2000","unstructured":"Gouttefangeas C, Diehl M, Keilholz W, H\u00f6rnlein RF, Stevanovi\u0107 S, Rammensee HG, et al. molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro. Blood. 2000;95:3168\u201375.","journal-title":"Blood"},{"key":"2749_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.hoc.2016.01.008","volume":"30","author":"SK Forest","year":"2016","unstructured":"Forest SK, Hod EA. Management of the Platelet Refractory Patient. Hematol Oncol Clin North Am. 2016;30:665\u201377.","journal-title":"Hematol Oncol Clin North Am"},{"key":"2749_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM196904032801401","volume":"280","author":"R Patel","year":"1969","unstructured":"Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280:735\u20139.","journal-title":"N Engl J Med"},{"key":"2749_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1056\/NEJM198901263200401","volume":"320","author":"C Anasetti","year":"1989","unstructured":"Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med. 1989;320:197\u2013204.","journal-title":"N Engl J Med"},{"key":"2749_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","volume":"14","author":"J Mattsson","year":"2008","unstructured":"Mattsson J, Ringd\u00e9n O, Storb R. Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2008;14:165\u201370.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2749_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/00007890-200204270-00014","volume":"73","author":"C S\u00fcsal","year":"2002","unstructured":"S\u00fcsal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation. 2002;73:1269\u201373.","journal-title":"Transplantation"},{"key":"2749_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","volume":"88","author":"SO Ciurea","year":"2009","unstructured":"Ciurea SO, de Lima M, Cano P, Korbling M, Giralt S, Shpall EJ, et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation. 2009;88:1019\u201324.","journal-title":"Transplantation"},{"key":"2749_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5045\/br.2022.2021229","volume":"57","author":"HJ Youk","year":"2022","unstructured":"Youk HJ, Hwang SH, Oh HB, Ko DH. Evaluation and management of platelet transfusion refractoriness. Blood Res. 2022;57:6\u201310.","journal-title":"Blood Res"},{"key":"2749_CR19","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1111\/trf.12739","volume":"54","author":"B Rioux-Mass\u00e9","year":"2014","unstructured":"Rioux-Mass\u00e9 B, Cohn C, Lindgren B, Pulkrabek S, McCullough J. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion. Transfusion. 2014;54:3080\u20137.","journal-title":"Transfusion"},{"key":"2749_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.autrev.2011.04.028","volume":"10","author":"GJ Pons-Estel","year":"2011","unstructured":"Pons-Estel GJ, Salerni GE, Serrano RM, Gomez-Puerta JA, Plasin MA, Aldasoro E, et al. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. Autoimmun Rev. 2011;10:679\u201384.","journal-title":"Autoimmun Rev"},{"key":"2749_CR21","unstructured":"Weinstein R. Basic principles of therapeutic blood exchange. In: McLeod BC, Weinstein R, Winters JL, Szczepiorkowski ZM, editors. Apheresis: principles and practice. 3rd ed. Bethesda: AABB Press; 2010. pp. 269\u201394."},{"key":"2749_CR22","doi-asserted-by":"crossref","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:171\u2013354.","DOI":"10.1002\/jca.21705"},{"key":"2749_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","volume":"11","author":"L Xu","year":"2018","unstructured":"Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, et al. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol. 2018;11:33.","journal-title":"J Hematol Oncol"},{"key":"2749_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2141.2004.04865.x","volume":"125","author":"P Rebulla","year":"2004","unstructured":"Rebulla P, Morelati F, Revelli N, Villa MA, Paccapelo C, Nocco A, et al. Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products. Br J Haematol. 2004;125:83\u20139.","journal-title":"Br J Haematol"},{"key":"2749_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jcla.21750","volume":"29","author":"N Sareban","year":"2015","unstructured":"Sareban N, Macher S, Drexler C, Posch U, Lanzer G, Schallmoser K. Platelet antibody analysis by three different tests. J Clin Lab Anal. 2015;29:198\u2013202.","journal-title":"J Clin Lab Anal"},{"key":"2749_CR26","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","volume":"116","author":"M Takanashi","year":"2010","unstructured":"Takanashi M, Atsuta Y, Fujiwara K, Kodo H, Kai S, Sato H, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116:2839\u201346.","journal-title":"Blood"},{"key":"2749_CR27","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/trf.12175","volume":"53","author":"K Pavenski","year":"2013","unstructured":"Pavenski K, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, et al. International Collaboration for Guideline Development, Implementation and Evaluation for Transfusion Therapies (ICTMG) Collaborators. Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review. Transfusion. 2013;53:2230\u201342.","journal-title":"Transfusion"},{"key":"2749_CR28","doi-asserted-by":"publisher","first-page":"4025073","DOI":"10.1155\/2016\/4025073","volume":"2016","author":"P Kongtim","year":"2016","unstructured":"Kongtim P, Cao K, Ciurea SO. Donor specific anti-HLA antibody and risk of graft failure in haploidentical stem cell transplantation. Adv Hematol. 2016;2016:4025073.","journal-title":"Adv Hematol"},{"key":"2749_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1600-6143.2003.00646.x","volume":"5","author":"CM Bearden","year":"2005","unstructured":"Bearden CM, Agarwal A, Book BK, Vieira CA, Sidner RA, Ochs HD, et al. Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant. 2005;5:50\u20137.","journal-title":"Am J Transplant"},{"key":"2749_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/bjh.16385","volume":"189","author":"P Vo","year":"2020","unstructured":"Vo P, Purev E, West KA, McDuffee E, Worthy T, Cook L, et al. A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients. Br J Haematol. 2020;189:551\u20138.","journal-title":"Br J Haematol"},{"key":"2749_CR31","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s41409-020-0928-z","volume":"55","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Xu LP, Wang Y, Zhang XH, Chen H, Chen YH, et al. Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transpl. 2020;55:1326\u201336.","journal-title":"Bone Marrow Transpl"},{"key":"2749_CR32","doi-asserted-by":"publisher","first-page":"674658","DOI":"10.3389\/fimmu.2021.674658","volume":"12","author":"R Bail\u00e9n","year":"2021","unstructured":"Bail\u00e9n R, Vicario JL, Sol\u00e1n L, S\u00e1nchez-Vadillo I, Herrera P, Calbacho M, et al. Management of donor-specific antibodies in haploidentical transplant: multicenter experience from the Madrid group of hematopoietic transplant. Front Immunol. 2021;12:674658.","journal-title":"Front Immunol"},{"key":"2749_CR33","first-page":"149","volume":"31","author":"J Schwartz","year":"2016","unstructured":"Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher. 2016;31:149\u201362.","journal-title":"J Clin Apher"},{"key":"2749_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","volume":"53","author":"SO Ciurea","year":"2018","unstructured":"Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, et al. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transpl. 2018;53:521\u201334.","journal-title":"Bone Marrow Transpl"},{"key":"2749_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1399-0012.2008.00902.x","volume":"23","author":"Z Kaposztas","year":"2009","unstructured":"Kaposztas Z, Podder H, Mauiyyedi S, Illoh O, Kerman R, Reyes M, et al. Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant. 2009;23:63\u201373.","journal-title":"Clin Transplant"},{"key":"2749_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/09537104.2014.895922","volume":"26","author":"J Cid","year":"2015","unstructured":"Cid J, Magnano L, Acosta M, Alba C, Esteve J. Lozano M. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness. Platelets. 2015;26:190\u20134.","journal-title":"Platelets"},{"key":"2749_CR37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00277-022-04844-5","volume":"101","author":"X Zheng","year":"2022","unstructured":"Zheng X, Yan H, Han D, Ding L, Zhu L, Liu J, et al. Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts. Ann Hematol. 2022;101:1777\u201383.","journal-title":"Ann Hematol"},{"key":"2749_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.transci.2019.04.007","volume":"58","author":"M Fern\u00e1ndez-Zarzoso","year":"2019","unstructured":"Fern\u00e1ndez-Zarzoso M, G\u00f3mez-Segu\u00ed I, de la Rubia J. Therapeutic plasma exchange: review of current indications. Transfus Apher Sci. 2019;58:247\u201353.","journal-title":"Transfus Apher Sci"},{"key":"2749_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-017-0487-y","volume":"10","author":"N Epperla","year":"2017","unstructured":"Epperla N, Ahn KW, Ahmed S, Jagasia M, DiGilio A, Devine SM, et al. Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma. J Hematol Oncol. 2017;10:117.","journal-title":"J Hematol Oncol"},{"key":"2749_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378:549\u201362.","journal-title":"N Engl J Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02749-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02749-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02749-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:20:34Z","timestamp":1775571634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02749-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02749-1","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}